title: VEGF inhibition beyond tumour progression.
authors.affiliation: Division of Medical Oncology, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA. Grothey.axel@mayo.edu
authors.forename: Axel
authors.initials: A
authors.lastname: Grothey
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab